The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab

The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab

The phenotypic spectrum of myelin oligodendrocyte glycoprotein (MOG)- IgG–associated disorders (MOGAD) has broadened in the past few years, and atypical phenotypes are increasingly recognized. Isolated seizures and MRI-negative brainstem and cerebellar symptoms or encephalitis have rarely been repor...

Full description

Bibliographic Details
Main Authors:	Rui Zhang, Li Wang, Yongli Tao, Xiaofeng Zhang, Kai Liu, Bo Song, Yuming Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Immunology
Subjects:	isolated seizures N-methyl-D-aspartate receptor myelin oligodendrocyte glycoprotein autoimmune encephalitis overlap syndrome ofatumumab
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1183488/full

Similar Items

Case report: Overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity
by: Jie Fu, et al.
Published: (2022-08-01)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
by: Satomi Hiya, et al.
Published: (2023-06-01)

Relapsing MOG-IgG-associated diseases coexisting with anti-NMDAR encephalitis: a case report and literature review
by: Mengmeng Wang, et al.
Published: (2022-04-01)

Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
by: Klaus Berek, et al.
Published: (2022-11-01)

MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews
by: Jiwon Yang, et al.
Published: (2023-12-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)

Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?
by: Feliciana Real-Fernández, et al.
Published: (2019-10-01)

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports
by: Hongfei Xue, et al.
Published: (2023-01-01)

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. <i>Diagnostics</i> 2023, <i>13</i>, 2481
by: Sohyeon Kim, et al.
Published: (2023-10-01)

The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
by: Michał Borończyk, et al.
Published: (2023-08-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
by: Halil Önder
Published: (2019-06-01)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
by: Xueshan Dong, et al.
Published: (2023-05-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Recurrent Salmonellosis Complicating Ofatumumab Therapy for Multiple Sclerosis
by: Justin Franco, et al.
Published: (2023-12-01)

Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody
by: Meihui Xu, et al.
Published: (2023-07-01)

The Clinical Features of FLAIR-Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review
by: Yun-feng Wang, et al.
Published: (2021-06-01)

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
by: Julia Baguña Torres, et al.
Published: (2022-07-01)

Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
by: Yi Hua, et al.
Published: (2023-08-01)

Anti-MOG Antibody-Associated Unilateral Cortical Encephalitis with Bilateral Meningeal Involvement: A Case Report
by: Bo Ren, et al.
Published: (2023-02-01)

Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report
by: Ryan D. Sorensen, et al.
Published: (2024-02-01)

Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review
by: Cong Zhao, et al.
Published: (2022-07-01)

Phenotypic Characteristics and Recurrence Factors of MOG-IgG Associated Disorders in Children
by: WANG Xin, ZHAO Ruibin, YANG Huafang, LIU Chong, LIU Tian, LU Cui, CHEN Didi
Published: (2023-06-01)

Response Surface Methodology Approach to Optimize the Expression of Thioredoxin-MOG Fusion Protein
by: Maryam Radmard, et al.
Published: (2024-04-01)

Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
by: Shambaditya Das, et al.
Published: (2023-03-01)

Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews
by: Yoonkyung Lee, et al.
Published: (2023-04-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
by: Leilei Mao, et al.
Published: (2019-08-01)

Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China
by: Jue Shen, et al.
Published: (2022-11-01)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
by: Giovanna S. Manzano, et al.
Published: (2022-06-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as unilateral cerebral cortical encephalitis: a case report
by: Ji-Yoon An, et al.
Published: (2024-04-01)

A Systematic Review of Efficacy and Safety of Ofatumumab Therapy in Children With Difficult-to-treat Nephrotic Syndrome
by: Yalda Ravanshad, et al.
Published: (2020-10-01)

Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
by: Nithisha Thatikonda, et al.
Published: (2020-04-01)

New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies
by: Hansol Im, et al.
Published: (2021-04-01)

Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously
by: Yijun Ren, et al.
Published: (2019-12-01)

MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?
by: Dominika Czarnecka, et al.
Published: (2019-10-01)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
by: Philippe Horellou, et al.
Published: (2021-06-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
by: Sven Jarius, et al.
Published: (2020-09-01)

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review
by: Keiko Tanaka, et al.
Published: (2023-08-01)

Investigating the association between neoplasms and MOG antibody-associated disease
by: Milena Trentinaglia, et al.
Published: (2023-06-01)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
by: Helen Cross, et al.
Published: (2021-01-01)